Condition (MeSH)
Yersinia Infections
ClinicalTrials.gov lists 13 trials for Yersinia Infections or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
1 of the 13 trials are tagged with Yersinia Infections itself; the rest are tagged with a narrower condition beneath it.
When did Yersinia Infections trials start? (9)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 2/3
- Phase 3
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2022 | 1 |
| 2020 | 3 |
| 2017 | 1 |
| 2014 | 1 |
| 2012 | 1 |
| 2010 | 2 |
| 2005 | 1 |
| 2004 | 2 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 13 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Yersinia Infections trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 5 |
| Phase 2/3 | 1 |
| Phase 3 | 1 |
| Observational | 3 |
How many Yersinia Infections trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Completed | 10 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Yersinia Infections trials? (7)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Centers for Disease Control and Prevention | 2 |
| DynPort Vaccine Company LLC, A GDIT Company | 2 |
| Jiangsu Province Centers for Disease Control and Prevention | 2 |
| Brimrose Technology Corporation | 1 |
| Dynavax Technologies Corporation | 1 |
Showing 5 of 7 sponsors.
Which drugs are being tested for Yersinia Infections? (3)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Plague vaccine | 2 |
| Streptomycin | 2 |
| Aluminum hydroxide | 1 |
Interventions as named in the registry (7)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| rF1V vaccine | 3 |
| PO ciprofloxacin | 2 |
| Gentamicins | 2 |
| rF1V-1018 | 1 |
| rF1 and rV protein antigens | 1 |
Showing 5 of 7 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Yersinia Infections trials report? (6)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Appendicitis | 1 | 1 |
| Complicated Appendicitis | 1 | 1 |
| Cor Pulmonale Acute | 1 | 1 |
| Deep Vein Thrombosis | 1 | 1 |
| Pulmonary Embolism | 1 | 1 |
Showing 5 of 6 adverse events.
Which publications cover Yersinia Infections? (4)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Prevalence of <i>Yersinia</i> Species in the Ileum of Crohn's Disease Patients and Controls. | Frontiers in cellular and infection microbiology | 2018 | Yes |
| Influence of antibiotics on IgA and IgG response and persistence of Yersinia enterocolitica in patients with Yersinia-associated spondylarthropathy. | Infection | 1992 | Yes |
| Pathogen-specific risk of chronic gastrointestinal disorders following bacterial causes of foodborne illness. | BMC gastroenterology | 2013 | No |
| Incidence and trends of infection with pathogens transmitted commonly through food - foodborne diseases active surveillance network, 10 U.S. sites, 1996-2012. | MMWR. Morbidity and mortality weekly report | 2013 | No |
Sub-conditions in MeSH (2)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence and rare-disease identity.